Viatris is a well-known global healthcare major with operations spread across North America, Europe, China, and other markets. The company’s financial performance has been in recovery mode and has been impacted by numerous industry headwinds, especially inflationary pressures. It had an interesting set of developments which included a strategic agreement to sell off their biosimilars business to Biocon Biologics. Besides, Tyrvaya's clinical development for new indications, like neurotrophic kera ....
02 Jan 2023
Viatris Inc: Detailed Credit Analysis & Financial Strength Evaluation Report, Key Risks & ESG Assessment (12/2022)
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Viatris Inc: Detailed Credit Analysis & Financial Strength Evaluation Report, Key Risks & ESG Assessment (12/2022)
Viatris is a well-known global healthcare major with operations spread across North America, Europe, China, and other markets. The company’s financial performance has been in recovery mode and has been impacted by numerous industry headwinds, especially inflationary pressures. It had an interesting set of developments which included a strategic agreement to sell off their biosimilars business to Biocon Biologics. Besides, Tyrvaya's clinical development for new indications, like neurotrophic kera ....